AAAAAA

   
Results: 1-8 |
Results: 8
Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation
Authors: Shimoni, A Gajewski, J Donato, M Martin, T O'Brien, S Talpaz, M Cohen, A Korbling, M Champlin, R Giralt, S
Citation: A. Shimoni et al., Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation, BIOL BLOOD, 7(10), 2001, pp. 568-575
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma
Authors: Shimoni, A Smith, TL Aleman, A Weber, D Dimopoulos, M Anderlini, P Andersson, B Claxton, D Ueno, NT Khouri, I Donato, M Korbling, M Alexanian, R Champlin, R Giralt, S
Citation: A. Shimoni et al., Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma, BONE MAR TR, 27(8), 2001, pp. 821-828
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation
Authors: Champlin, R Khouri, I Anderlini, P Gajewski, J Kornblau, S Molldrem, J Shimoni, A Ueno, N Giralt, S
Citation: R. Champlin et al., Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation, BONE MAR TR, 27, 2001, pp. S13-S22
Skeletal sarcoidosis: Successful treatment with hydroxychloroquine
Authors: Shimoni, A Hershcovici, T Mekhmandarov, S Maor-Kendler, Y Beigel, Y
Citation: A. Shimoni et al., Skeletal sarcoidosis: Successful treatment with hydroxychloroquine, ISR MED ASS, 2(7), 2000, pp. 558-559
Cryofibrinogenemia acid skin necrosis in a patient with diffuse large celllymphoma after high-dose chemotherapy and autologous stem cell transplantation
Authors: Shimoni, A Korbling, M Champlin, R Molldrem, JI
Citation: A. Shimoni et al., Cryofibrinogenemia acid skin necrosis in a patient with diffuse large celllymphoma after high-dose chemotherapy and autologous stem cell transplantation, BONE MAR TR, 26(12), 2000, pp. 1343-1345
Harnessing graft-versus-malignancy: Non-myeloablative preparative regimensfor allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy
Authors: Champlin, R Khouri, I Shimoni, A Gajewski, J Kornblau, S Molldrem, J Ueno, N Giralt, S Anderlini, P
Citation: R. Champlin et al., Harnessing graft-versus-malignancy: Non-myeloablative preparative regimensfor allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy, BR J HAEM, 111(1), 2000, pp. 18-29
Refractory pure red cell aplasia associated with B-CLL: successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin
Authors: Shimoni, A Shvidel, L Klepfish, A Shtalrid, M Sigler, E Berrebi, A
Citation: A. Shimoni et al., Refractory pure red cell aplasia associated with B-CLL: successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin, LEUKEMIA, 13(1), 1999, pp. 142-143
Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human -> mouse radiation chimera
Authors: Shimoni, A Marcus, H Dekel, B Shkarchi, R Arditti, F Shvidel, L Shtalrid, M Bucher, W Canaan, A Ergas, D Berrebi, A Reisner, Y
Citation: A. Shimoni et al., Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human -> mouse radiation chimera, CANCER RES, 59(23), 1999, pp. 5968-5974
Risultati: 1-8 |